NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,299,143 | -6.1% | 2,492,636 | +3.3% | 9.33% | -4.9% |
| Q2 2023 | $117,454,875 | -25.0% | 2,413,787 | -14.4% | 9.82% | -10.0% |
| Q1 2023 | $156,553,630 | +45.1% | 2,819,770 | +5.0% | 10.92% | +15.5% |
| Q4 2022 | $107,894,973 | +72.7% | 2,685,959 | +88.4% | 9.45% | +74.5% |
| Q3 2022 | $62,469,880 | +270.6% | 1,425,602 | +199.7% | 5.41% | +351.9% |
| Q2 2022 | $16,857,213 | +76.8% | 475,655 | +366.0% | 1.20% | +96.7% |
| Q4 2021 | $9,532,411 | -23.8% | 102,071 | -9.0% | 0.61% | -29.8% |
| Q3 2021 | $12,502,342 | +1082.3% | 112,189 | +1104.5% | 0.87% | +1140.0% |
| Q2 2021 | $1,057,418 | -82.0% | 9,314 | -83.9% | 0.07% | -84.1% |
| Q1 2021 | $5,858,858 | +10.7% | 57,700 | -63.3% | 0.44% | -52.9% |
| Q4 2019 | $5,292,059 | +858.8% | 157,081 | +297.3% | 0.94% | +212.7% |
| Q4 2018 | $551,964 | – | 39,539 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |